Picking Paths in CLL: Fresh Approaches and Tools to Individualize Treatment Across the Disease Spectrum

Gain in-depth knowledge and take-home strategies to improve outcomes and better individualize treatment for patients with CLL through a series of expert ClinicalThought commentaries, text modules with accompanying downloadable slides, and an interactive decision support tool.

Share

Program Content

Activities

CLL 1L Therapy
Key Considerations in Selecting Frontline Therapy for Patients With CLL/SLL
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 24, 2024

Expires: April 23, 2025

CLL/SLL: 2L Therapy
Key Considerations in Selecting Second-line Therapy for Patients With CLL/SLL
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 15, 2024

Expires: May 14, 2025

Faculty

cover img faculity

Nicole Lamanna, MD

Judy Horrigan Professor of Medicine
Director of the Chronic Lymphocytic Leukemia Program
Leukemia Service
Herbert Irving Comprehensive Cancer Center
Columbia University Medical Center/NewYork-Presbyterian
New York, New York

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC in partnership with CLL Society.

Supporters

Supported by educational grants from AbbVie Inc.; AstraZeneca; Beigene, Ltd.; and Bristol Myers Squibb.

AbbVie Inc.

AstraZeneca

BeiGene, Ltd.

Bristol Myers Squibb

Partners

CLL Society

ProCE Banner